Corient Private Wealth LLC Sells 7,547 Shares of Ventas, Inc. $VTR

Corient Private Wealth LLC trimmed its position in shares of Ventas, Inc. (NYSE:VTR) by 8.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 83,790 shares of the real estate investment trust’s stock after selling 7,547 shares during the quarter. Corient Private Wealth LLC’s holdings in Ventas were worth $5,292,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of VTR. Ameritas Advisory Services LLC purchased a new position in Ventas in the 2nd quarter worth about $33,000. Golden State Wealth Management LLC increased its position in Ventas by 52.7% in the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 185 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new stake in Ventas during the 2nd quarter worth approximately $35,000. IFP Advisors Inc lifted its stake in shares of Ventas by 61.3% during the 2nd quarter. IFP Advisors Inc now owns 974 shares of the real estate investment trust’s stock valued at $62,000 after buying an additional 370 shares in the last quarter. Finally, CYBER HORNET ETFs LLC bought a new position in shares of Ventas in the second quarter worth about $67,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Down 1.0%

Shares of VTR opened at $79.13 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. Ventas, Inc. has a 52 week low of $56.68 and a 52 week high of $81.89. The stock’s 50-day moving average price is $76.06 and its 200-day moving average price is $69.84. The company has a market capitalization of $37.17 billion, a price-to-earnings ratio of 152.18, a PEG ratio of 1.99 and a beta of 0.78.

Ventas (NYSE:VTR) last posted its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.01. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period in the previous year, the firm earned $0.80 EPS. The business’s quarterly revenue was up 20.5% on a year-over-year basis. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. On average, sell-side analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.48 per share. The ex-dividend date is Wednesday, December 31st. This represents a $1.92 dividend on an annualized basis and a yield of 2.4%. Ventas’s dividend payout ratio is currently 369.23%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Scotiabank lifted their target price on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a report on Thursday, November 13th. JPMorgan Chase & Co. boosted their price objective on shares of Ventas from $72.00 to $76.00 and gave the company an “overweight” rating in a research report on Tuesday, August 26th. Weiss Ratings lowered Ventas from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, December 15th. Citigroup increased their target price on Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Finally, Cantor Fitzgerald boosted their price objective on shares of Ventas from $77.00 to $85.00 and gave the stock an “overweight” rating in a research note on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Ventas currently has an average rating of “Moderate Buy” and a consensus target price of $79.31.

Insider Transactions at Ventas

In related news, CFO Robert F. Probst sold 33,591 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $76.77, for a total value of $2,578,781.07. Following the completion of the sale, the chief financial officer owned 168,364 shares of the company’s stock, valued at approximately $12,925,304.28. This represents a 16.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Debra A. Cafaro sold 41,294 shares of Ventas stock in a transaction on Monday, November 17th. The shares were sold at an average price of $79.01, for a total value of $3,262,638.94. Following the completion of the sale, the chief executive officer owned 1,145,695 shares in the company, valued at $90,521,361.95. This represents a 3.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 688,184 shares of company stock valued at $50,726,248 over the last ninety days. Insiders own 0.80% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.